Company
Clinuvel Pharmaceuticals
ASX:CUV
Clinuvel Pharmaceuticals (ASX:CUV) is listed on the Australian Securities Exchange.
17 stories
Volatile ASX finishes higher as banks get an upgrade to outperform
The banks are up 3.2% since the start of February and have outperformed the share market by approximately 1.5% year to date, largely due to better-than-expected earnings updates.
The ASX is higher, but looks to be faltering as we close out the week
“That said, as always, I urge investors to protect their capital in case it falls further. Medium term, I believe once we confirm the low, our market will have a very nice run up this year and continue in a longer-term uptrend until the mid
Investments and investor services
S&P/ASX 200 having tough day as S&P Dow Jones quarterly rebalance rings changes
S&P/ASX 200 (INDEXASX:XJO) (ASX:XJO) is down 55 points or 0.90% to 6,105 points around lunch.
Clinuvel Pharmaceuticals Ltd prepares for new drug application in the U.S.
Clinuvel Pharmaceuticals Ltd (ASX:CUV) has met with the U.S. Food and Drug Administration (FDA) to discuss the content and format of a new drug application (NDA) for its product SCENESSE.